Live feed
Filing
SC 13D
SC 13D0000903423-19-000277·BridgeBio Pharma, Inc.
Schedule 13D ownership disclosure
BRIDGEBIO PHARMA INC
Security class unavailable · CUSIP: 10806X102
Event date: 2019-06-27
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 26,620,991
- Percent of class
- 22.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000903423-19-000277
- Form type
- SC 13D
- Filer
- BridgeBio Pharma, Inc.
- CIK
- CIK 1743881
- Filed
- Jul 08, 2019
- Reporting period
- Jun 27, 2019
- Description
- Schedule 13D beneficial ownership